These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1855925)

  • 1. Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA.
    Farmer PB; Bailey E; Green JA; Leung CS; Manson MM
    IARC Sci Publ; 1991; (105):71-7. PubMed ID: 1855925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel uses of mass spectrometry in studies of adducts of alkylating agents with nucleic acids and proteins.
    Farmer PB; Lamb J; Lawley PD
    IARC Sci Publ; 1988; (89):347-55. PubMed ID: 3198219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts.
    Weston A; Willey JC; Manchester DK; Wilson VL; Brooks BR; Choi JS; Poirier MC; Trivers GE; Newman MJ; Mann DL
    IARC Sci Publ; 1988; (89):181-9. PubMed ID: 3143667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of alkylated proteins in the monitoring of exposure to alkylating agents.
    Farmer PB; Bailey E; Campbell JB
    IARC Sci Publ; 1984; (59):189-98. PubMed ID: 6545280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: application to unidentified genotoxicants.
    Randerath K; Miller RH; Mittal D; Randerath E
    IARC Sci Publ; 1988; (89):361-7. PubMed ID: 3198221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for simultaneous identification of human active and active-site alkylated O6-methylguanine-DNA methyltransferase and its possible application for monitoring human exposure to alkylating carcinogens.
    Ayi TC; Oh HK; Lee TK; Li BF
    Cancer Res; 1994 Jul; 54(14):3726-31. PubMed ID: 8033092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring occupational exposure to carcinogens.
    Schoket B
    IARC Sci Publ; 1993; (124):341-7. PubMed ID: 8225504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dosimetry of DNA and protein adducts in occupational health].
    Pavanello S; Clonfero E
    Med Lav; 1994; 85(5):363-9. PubMed ID: 7885291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of human exposure to carcinogens through DNA and protein adduct determination.
    Farmer PB
    Toxicol Lett; 1995 Dec; 82-83():757-62. PubMed ID: 8597139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of O6-methylguanine in human DNA.
    Saffhill R; Badawi AF; Hall CN
    IARC Sci Publ; 1988; (89):301-5. PubMed ID: 3198214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of styrene oxide-DNA adducts in lymphocytes of a worker exposed to styrene.
    Liu SF; Rappaport SM; Pongracz K; Bodell WJ
    IARC Sci Publ; 1988; (89):217-22. PubMed ID: 3198203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic DNA adducts in white blood cells of foundry workers.
    Hemminki K; Perera FP; Phillips DH; Randerath K; Reddy MV; Santella RM
    IARC Sci Publ; 1988; (89):190-5. PubMed ID: 3143668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of styrene oxide/haemoglobin adducts by mass spectrometry: identification of suitable biomarkers for human exposure evaluation.
    Basile A; Ferranti P; Mamone G; Manco I; Pocsfalvi G; Malorni A; Acampora A; Sannolo N
    Rapid Commun Mass Spectrom; 2002; 16(9):871-8. PubMed ID: 11948819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical analysis of biomonitoring endpoints for measuring exposure to polymeric diphenyl-methane-4,4'-diisocyanate (MDI) in rats: a comparison of markers of exposure and markers of effect.
    Pauluhn J
    Arch Toxicol; 2002 Feb; 76(1):13-22. PubMed ID: 11875620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomonitoring of aquatic systems.
    Kurelec B; Gupta RC
    IARC Sci Publ; 1993; (124):365-72. PubMed ID: 8225508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of beta-propiolactone and some related alkylating agents to DNA, RNA, and protein of mouse skin; relation between tumor-initiating power of alkylating agents and their binding to DNA.
    Colburn NH; Boutwell RK
    Cancer Res; 1968 Apr; 28(4):653-60. PubMed ID: 5649056
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotoxicity of environmental agents assessed by the alkaline comet assay.
    Møller P
    Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of DNA alkylphosphotriesters by 32P postlabeling: evidence for the nonrandom manifestation of phosphotriester lesions in vivo.
    Guichard Y; Jones GD; Farmer PB
    Cancer Res; 2000 Mar; 60(5):1276-82. PubMed ID: 10728687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.